Knee prostheses
This article was originally published in The Gray Sheet
Executive Summary
FDA's special controls guidance for knee joint patellofemorotibial and femorotibial metal/polymer porous-coated uncemented prostheses posted Feb. 7 identifies four risks associated with the devices: adverse tissue reaction, infection, pain and/or loss of function and revision surgery. FDA issued a preliminary notice announcing its intent to downclassify the devices from Class III to Class II in March 2000 (1"The Gray Sheet" March 13, 2000, p. 9)...
You may also be interested in...
MDR System Adequate For Knee Prostheses Adverse Events, Agency Says
FDA's medical device reporting system is adequate for reporting adverse events that might occur with fixed-bearing, cementless femoro-tibial unicompartmental knee prostheses, the agency says in a March 7 preliminary notice to downclassify the devices from Class III to Class II.
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.